Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Korea Signals Continued Policy Support For Pharma In 2018

Executive Summary

Despite the regime change, South Korea remained generally supportive of the pharma and biotech industry in 2017. With comprehensive long-term plans proposed to nurture these sectors, the government appears poised to pursue its favorable stance towards industry in the coming year.

Advertisement

Related Content

Korea Unveils 5-Year Roadmap To Nurture Domestic Industry
Tagrisso Reimbursed In Korea, After Difficult Price Negotiations
Korea’s Biotech Roadmap Aims To Bridge Funding Gaps
Korea Takes Its First Step Reimbursing IO Drugs
Korea's Reimbursement Steps Spark Drug Price Cut Concerns
State-Owned Pharma Group On Horizon As Korea Eyes Secure Supplies

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

PS122212

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel